Access

Business

Nature 440, 991 (20 April 2006) | doi:10.1038/440991a; Published online 19 April 2006

Open Innovation Challenges

naturejobs

In brief

Serono, Europe's largest biotechnology company, is no longer up for sale. Instead, the firm says that it is seeking allies and smaller acquisitions to strengthen its drug pipeline.